Skip to main content
Scienza Health
NeurodegenerativePrimary Care

Huntington's Disease Screening in Primary Care Practices

GIA® screens for Huntington's Disease in primary care practices through a single conversational interaction lasting 40 seconds. She analyzes over 2,500 speech biomarkers using Voice AI, Computer Vision, and Speech Biomarkers. Screening performance: Clinically validated vocal biomarker screening. Results are delivered to the clinician in under 2 minutes. Zero additional staff required. Peer-reviewed across 19 published studies.

GIA® conducts the screening conversation in the waiting room, during rooming, or before the physician enters — patient talks with GIA for 40 seconds and the results write back to the EHR for clinician review under 2 minutes. The physician sees structured cognitive, depression, and anxiety screening data during the visit instead of running each assessment separately.

Screening PerformanceClinically validated vocal biomarker screening
THE CHALLENGE

Why Huntington's Disease goes undetected in primary care practices

A primary-care physician sees 18–25 patients per day in 15–20 minute slots. Medical assistants triage and prepare. Adding cognitive screening to the existing workflow without extending visit length or adding staff is the operational constraint. Huntington's Disease symptoms are often subtle, progressive, and easily attributed to other factors in this care environment.

The annual wellness visit (AWV) carries 25 minutes of face time — adding cognitive, behavioral, and functional screening burns through the visit

Documentation overhead per encounter directly affects encounter throughput and revenue-cycle efficiency — every additional screening tool compounds the per-visit documentation time

Reimbursable codes like G0438 (initial AWV), G0439 (subsequent AWV), and CPT 99483 (cognitive care plan visit) require documented screening that many practices skip due to time constraints

Value-based-care contracts increasingly tie compensation to cognitive-screening completion rates and HCC capture in Medicare Advantage populations

HOW IT WORKS

How does GIA® screen for Huntington's Disease in primary care practices?

GIA® meets the patient by video, voice, or landline — wherever they are in the primary care practice environment. The screening conversation takes 40 seconds and feels like a natural check-in, not a clinical assessment.

During the conversation, GIA® analyzes over 2,500 speech biomarkers — including vocal tremor, articulatory precision, prosodic patterns, and cognitive load indicators — alongside 436 visual data points from facial micro-expressions and body movement during video sessions.

Results are delivered to the clinician in under 2 minutes. Four data types write back to the EHR automatically: structured screening results with ICD-10 codes, clinician-ready medical notes, a full timestamped transcript, and the recorded patient video. The clinician reviews and submits — the human is always in the loop.

< 5 minscreening time
60sto clinician-ready results
2,500+speech biomarkers analyzed
0additional staff required
COMPLIANCE & DOCUMENTATION

What compliance requirements does this address?

G0438 (initial annual wellness visit) and G0439 (subsequent annual wellness visit) require documented cognitive assessment as a core element. CPT 99483 (Cognitive Care Plan visit) is separately reimbursable when a clinician documents cognitive impairment. CPT 96127 (brief emotional/behavioral assessment, scored standardized instrument) is reimbursable per administration and applies to depression and anxiety screening that GIA® supports alongside cognitive screening. MIPS Promoting Interoperability category measures reward consistent screening-workflow integration. Documentation supports billing accuracy; coding decisions remain with the clinical documentation and coding team.

GIA® produces structured documentation automatically — screening results with ICD-10 codes, clinician-ready medical notes, full timestamped transcripts, and recorded patient video — all written back to the EHR in real time and available for clinical, billing, and compliance review.

FREQUENTLY ASKED QUESTIONS

Huntington's Disease screening in primary care practices

How is Huntington's Disease screened in primary care practices?

GIA® screens for Huntington's Disease through a single conversational interaction lasting 40 seconds. She analyzes over 2,500 speech biomarkers using Voice AI, Computer Vision, and Speech Biomarkers. GIA® conducts the screening conversation in the waiting room, during rooming, or before the physician enters — patient talks with GIA for 40 seconds and the results write back to the EHR for clinician review under 2 minutes. The physician sees structured cognitive, depression, and anxiety screening data during the visit instead of running each assessment separately. Results are delivered to the clinician in under 2 minutes.

Does Huntington's Disease screening require additional staff?

No. GIA® conducts the screening conversation independently — zero additional clinical staff required during the interaction. A primary-care physician sees 18–25 patients per day in 15–20 minute slots. Medical assistants triage and prepare. Adding cognitive screening to the existing workflow without extending visit length or adding staff is the operational constraint. The clinician reviews the results in under 2 minutes.

What is the accuracy of Huntington's Disease screening?

Huntington's Disease screening accuracy: Clinically validated vocal biomarker screening. The platform is peer-reviewed across 19 published studies and trained on 12.3 million longitudinal PAC/LTC patient records and 27 billion clinical events.

FREE GUIDE

The Operator's Guide to Multimodal Clinical AI

What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.

See GIA® screen for Huntington's Disease live

40 seconds. 60-second results. Zero staff time.

Schedule a Demo